Amundi S&P Global Health Care ESG UCITS ETF DR EUR Acc (USD) | WEL9Register to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | - | 5.8 | |
+/-Cat | - | - | - | - | 3.8 | |
+/-B’mrk | - | - | - | - | 1.0 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
Closing Price 17/05/2024 | USD 12.40 | |
Day Change | -0.67% | |
Morningstar Category™ | Sector Equity Healthcare | |
Volume | 450 | |
Exchange | DEUTSCHER KASSENVEREIN AG GRUPPE DEUTSCHE BOERSE | |
ISIN | IE0006FM6MI8 | |
Fund Size (Mil) 16/05/2024 | EUR 245.96 | |
Share Class Size (Mil) 16/05/2024 | EUR 233.54 | |
Ongoing Charge 11/07/2023 | 0.65% |
Investment Objective: Amundi S&P Global Health Care ESG UCITS ETF DR EUR Acc (USD) | WEL9 |
To track the performance of the Index. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Quentin Berrou 20/09/2022 | ||
Shan Zhao 20/09/2022 | ||
Click here to see others | ||
Inception Date 20/09/2022 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
S&P Dev Ex-Kr LMCap Sust Enh HC NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Amundi S&P Global Health Care ESG UCITS ETF DR EUR Acc (USD) | WEL9 | 15/05/2024 |
|
|
Top 5 Holdings | Sector | % |
Eli Lilly and Co | Healthcare | 8.96 |
UnitedHealth Group Inc | Healthcare | 8.43 |
AbbVie Inc | Healthcare | 6.07 |
Novo Nordisk A/S Class B | Healthcare | 6.04 |
AstraZeneca PLC | Healthcare | 5.20 |
Increase Decrease New since last portfolio | ||
Amundi S&P Global Health Care ESG UCITS ETF DR EUR Acc (USD) | WEL9 |